MarketScreener Editorial Features Can-Fite BioPharma Ltd.

Equities

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:52 2025-07-14 am EDT			5-day change	1st Jan Change
1.300 ^ILa	0.00%		0.00%	-31.58%

Jun. 16	Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston	CI
May. 05	Can-Fite Says It Has Raised $175 Million To Date For Development Of Namodenoson And Piclidenoson	RE

No results for this search